Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu, Wei Chun HuangFu, Han Li Huang, Wei Cheng Wu, Yi Lin Chen, Yun Yen, Hsiang Ling Huang, Chih Ying Nien, Mei Jung Lai, Shiow Lin Pan, Jing Ping Liou

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number112633
JournalEuropean Journal of Medicinal Chemistry
Volume202
DOIs
Publication statusPublished - Sep 15 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)'. Together they form a unique fingerprint.

  • Cite this